Elite Pharmaceuticals, Inc. Interest Payable
Elite Pharmaceuticals, Inc. (ELTP) had Interest Payable of $6.74 thousand as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2023-02-14
- 2022-12-31: Interest Payable $6.74K.
- 2022-09-30: Interest Payable $6.74K.
- 2022-06-30: Interest Payable $29.47K.
- 2022-03-31: Interest Payable $7.37K; Interest Payable as first filed $435.00K.
| Period end | Interest Payable | Interest Payable as first filed |
|---|---|---|
| 2022-12-31 | $6.74K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $6.74K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $29.47K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $7.37K 10-Q · filed 2023-02-14 | $435.00K 10-K · filed 2022-06-29 |
| 2021-12-31 | $435.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $435.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $435.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $435.00K 10-K · filed 2022-06-29 | |
| 2020-12-31 | $435.00K 10-Q · filed 2022-02-14 | |
| 2013-03-31 | $13.15K 10-K · filed 2013-06-21 | |
| 2012-03-31 | $22.49K 10-K · filed 2013-06-21 | |
| 2011-03-31 | $0.00 10-K · filed 2013-06-21 |